Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter study of hydromorphone for emergency analgesia
ChiCTR2400089884Phase 4Not yet recruiting
- Sponsor
- Third People's Hospital of Chengdu
- Start
- Sep 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of hydromorphone in acute pain (2 arms), sponsored by Third People's Hospital of Chengdu. Primary endpoints: Pain relief rate at 2 hours, Time to target analgesia at 2 hours and 1 more. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
hydromorphone
03
Conditions
acute pain
Beyond the preview
Go deeper on ChiCTR2400089884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400089884.